Factors | Adjustment set | Levels | RRR (95% CI) | P-value | ||
---|---|---|---|---|---|---|
MME > 0–5 mg vs | MME > 5 mg vs | MME > 5 mg vs | ||||
MME 0 mg | MME 0 mg | MME > 0–5 | ||||
Sex | - | Male | 1 | 1 | 1 | < 0.001* |
Female | 1.36 (1.17, 1.59) | 1.00 (0.80, 1.25) | 0.73 (0.58, 0.93) | |||
Age | - | < 65 years old | 1 | 1 | 1 | 0.09 |
≥ 65 years old | 0.82 (0.69, 0.99) | 1.00 (0.77, 1.30) | 1.21 (0.92, 1.61) | |||
Religion | 0.62 | |||||
Buddhist | 1 | 1 | 1 | 1 | ||
Muslim | 0.85 (0.67, 1.08) | 0.82 (0.57,1.18) | 0.96 (0.65, 1.42) | 0.96 (0.65, 1.42) | ||
Christian | 1.40 (0.38, 5.24) | 1.01 (0.12, 8.68) | 0.72 (0.08, 6.47) | 0.72 (0.08, 6.47) | ||
ASA | Age, BMI, smoking | ASA I | 1 | 1 | 1 | 0.19 |
ASA II | 1.14 (0.85, 1.54) | 1.22 (0.76, 1.97) | 1.07 (0.64, 1.77) | |||
ASA III | 1.27 (0.90, 1.80) | 1.66 (0.97, 2.82) | 1.30 (0.74, 2.29) | |||
BMI | - | 25 - < 35 kg/m2 | 1 | 1 | 1 | < 0.001* |
< 25 kg/m2 | 1.28 (1.09, 1.50) | 1.17 (0.92, 1.48) | 0.91 (0.71, 1.18) | |||
≥ 35 kg/m2 | 1.88 (1.33, 2.66) | 1.84 (1.13, 3.00) | 0.98 (0.60, 1.61) | |||
Status | - | In-patient | 1 | 1 | 1 | 0.02* |
Out-patient | 0.57 (0.34, 0.96) | 0.43 (0.17, 1.08) | 0.76 (0.28, 2.05) | |||
ABO blood group | - | O | 1 | 1 | 1 | 0.26 |
A | 0.90 (0.73, 1.11) | 1.28 (0.96, 1.72) | 1.43 (1.05, 1.95) | |||
B | 1.02 (0.84, 1.23) | 1.06 (0.79, 1.41) | 1.04 (0.77, 1.41) | |||
AB | 1.16 (0.85, 1.58) | 0.94 (0.57, 1.54) | 0.81 (0.48, 1.36) | |||
Smoking | - | No | 1 | 1 | 1 | 0.48 |
Yes | 0.90 (0.75, 1.07) | 0.93 (0.71, 1.22) | 1.04 (0.78, 1.39) | |||
Premedication with benzodiazepine | - | No | 1 | 1 | 1 | 0.89 |
Yes | 1.06 (0.84, 1.34) | 1.03 (0.72, 1.45) | 1.03 (0.71, 1.49) | |||
Preoperative use of gabapentin | - | No | 1 | 1 | 1 | 0.002* |
Yes | 1.50 (1.00, 2.26) | 2.43 (1.48, 4.00) | 1.62 (0.97, 2.70) | |||
Preoperative use of pregabalin | - | No | 1 | 1 | 1 | 0.33 |
Yes | 1.07 (0.26, 4.49) | 3.12 (0.74, 13.09) | 2.91 (0.58, 14.49) | |||
Preoperative anxiety score | - | 0 | 1 | 1 | 1 | 0.008* |
1–5 | 0.99 (0.83, 1.18) | 1.47 (1.12, 1.92) | 1.48 (1.11, 1.96) | |||
6–10 | 1.02 (0.82, 1.26) | 1.74 (1.26, 2.39) | 1.69 (1.21, 2.37) | |||
Preoperative pain score | Sex, age, ABO blood group, benzodiazepine, gabapentin, pregabalin | 0 | 1 | 1 | 1 | 0.24 |
1–3 | 0.94 (0.74, 1.21) | 1.13 (0.79, 1.62) | 1.20 (0.82, 1.76) | |||
4–6 | 1.12 (0.87, 1.43) | 1.51 (1.08, 2.10) | 1.35 (0.94, 1.92) | |||
7–10 | 1.03 (0.72, 1.48) | 1.51 (0.94, 2.41) | 1.46 (0.88, 2.42) | |||
Anesthetic technique | - | GA | 1 | 1 | 1 | < 0.001* |
TCI | 0.18 (0.11, 0.31) | 0.10 (0.03, 0.32) | 0.55 (0.16, 1.91) | |||
Spinal block | 0.09 (0.06, 0.12) | 0.05 (0.02, 0.10) | 0.55 (0.27, 1.14) | |||
Nerve block | 0.11 (0.05, 0.25) | 0.05 (0.01, 0.38) | 0.49 (0.06, 4.11) | |||
Combined | 1.35 (1.06, 1.73) | 1.81 (1.32, 2.48) | 1.34 (0.98, 1.82) | |||
Others | 0.16 (0.06, 0.41) | 0.09 (0.01, 0.69) | 0.59 (0.07, 5.08) | |||
Amount of intraoperative opioid use (MME) | Age, ASA, BMI, anesthetic technique, duration of anesthesia, duration of surgery, type of operation, reoperation, blood loss | - | 1.01 (1.00, 1.02) | 1.01 (1.00, 1.03) | 1.00 (1.00, 1.01) | 0.02* |
Intraoperative use of paracetamol | - | No | 1 | 1 | 1 | 0.003* |
Yes | 2.02 (1.18, 3.44) | 2.85 (1.47, 5.51) | 1.41 (0.74, 2.71) | |||
Intraoperative use of parecoxib | - | No | 1 | 1 | 1 | < 0.001* |
Yes | 1.95 (1.45, 2.61) | 2.54 (1.74, 3.72) | 1.31 (0.89, 1.91) | |||
Intraoperative use of ketamine | - | No | 1 | 1 | 1 | 0.053 |
Yes | 0.47 (0.22, 1.03) | 0.34 (0.08, 1.43) | 0.72 (0.15, 3.42) | |||
Intraoperative use of ondansetron | - | No | 1 | 1 | 1 | < 0.001* |
Yes | 2.07 (1.78, 2.41) | 1.22 (0.97, 1.53) | 0.59 (0.46, 0.75) | |||
Duration of anesthesia | Duration of surgery | - | 1.00 (1.00, 1.00) | 1.00 (0.99, 1.00) | 1.00 (0.99, 1.00) | 0.02* |
Duration of surgery | - | - | 1.00 (1.00, 1.01) | 1.01 (1.00, 1.01) | 1.00 (1.00, 1.00) | < 0.001* |
Type of operation | - | General surgery | 1 | 1 | 1 | < 0.001* |
C-section | 0.06 (0.03, 0.12) | 0.09 (0.03, 0.26) | 1.61 (0.48, 5.44) | |||
Otolaryngology | 0.49 (0.38, 0.63) | 0.19 (0.11, 0.33) | 0.39 (0.22, 0.67) | |||
Gynecology | 0.79 (0.62, 1.01) | 0.88 (0.62, 1.24) | 1.11 (0.79, 1.58) | |||
Neurosurgery | 0.51 (0.29, 0.92) | 0.17 (0.04, 0.74) | 0.34 (0.08, 1.48) | |||
Obstetrics | 0.33 (0.19, 0.55) | 0.30 (0.13, 0.72) | 0.92 (0.36, 2.33) | |||
Ophthalmology | 0.30 (0.20, 0.46) | 0.06 (0.01, 0.24) | 0.19 (0.05, 0.82) | |||
Orthopedics | 0.37 (0.28, 0.48) | 0.63 (0.44, 0.90) | 1.71 (1.17, 2.49) | |||
Plastic | 0.73 (0.50, 1.05) | 0.92 (0.56, 1.53) | 1.26 (0.75, 2.12) | |||
Thoracic | 1.38 (0.48, 3.92) | 9.36 (3.65, 24.02) | 6.78 (2.98, 15.42) | |||
Urological | 0.28 (0.20, 0.39) | 0.75 (0.51, 1.10) | 2.65 (1.70, 4.12) | |||
Vascular | 0.26 (0.16, 0.42) | 0.14 (0.05, 0.39) | 0.54 (0.18, 1.58) | |||
Reoperation | - | No | 1 | 1 | 1 | 0.13 |
Yes | 1.56 (1.00, 2.42) | 1.42 (0.74, 2.72) | 0.91 (0.47, 1.76) | |||
Blood loss | Type of operation | Based on 1 ml | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | < 0.001* |
Based on 10 ml | 1.09 (1.06, 1.12) | 1.15 (1.11, 1.18) | 1.05 (1.02, 1.08) | < 0.001* | ||
Pain score upon PACU arrival (model 1) | ABO, age, anesthetic technique, benzodiazepine, blood loss, BMI, duration of anesthesia, intraoperative use of parecoxib, gabapentin, amount of intraoperative opioid use (MME), intraoperative use of ketamine, intraoperative use of paracetamol, preoperative anxiety, pregabalin, preoperative pain score, status, religious, reoperation, sex, smoking, duration of surgery, type of operation | - | 2.09 (1.98, 2.21) | 3.03 (2.79, 3.30) | 1.45 (1.36, 1.55) | < 0.001* |
Pain score upon PACU arrival (model 2) | Age, anesthetic technique, ASA, benzodiazepine, BMI, intraoperative use of parecoxib, gabapentin, amount of intraoperative opioid use (MME), intraoperative use of ketamine, intraoperative use of paracetamol, preoperative anxiety, pregabalin, preoperative pain score, religious, reoperation, sex, smoking, duration of surgery, type of operation | - | 2.09 (1.98, 2.21) | 3.04 (2.79, 3.30) | 1.45 (1.36, 1.55) | < 0.001* |
Use of paracetamol in PACU | - | No | 1 | 1 | 1 | < 0.001* |
Yes | 2.06 (1.14, 3.72) | 9.41 (5.41, 16.37) | 4.56 (2.68, 7.78) | |||
Use of parecoxib in PACU | - | No | 1 | 1 | 1 | < 0.001* |
Yes | 3.76 (2.13, 6.64) | 15.32 (8.79, 26.72) | 4.07 (2.60, 6.38) |